JP2019533642A5 - - Google Patents

Download PDF

Info

Publication number
JP2019533642A5
JP2019533642A5 JP2019513944A JP2019513944A JP2019533642A5 JP 2019533642 A5 JP2019533642 A5 JP 2019533642A5 JP 2019513944 A JP2019513944 A JP 2019513944A JP 2019513944 A JP2019513944 A JP 2019513944A JP 2019533642 A5 JP2019533642 A5 JP 2019533642A5
Authority
JP
Japan
Prior art keywords
optionally substituted
composition
mammal
membered
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019513944A
Other languages
English (en)
Japanese (ja)
Other versions
JP7065081B2 (ja
JP2019533642A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/050964 external-priority patent/WO2018049328A1/en
Publication of JP2019533642A publication Critical patent/JP2019533642A/ja
Publication of JP2019533642A5 publication Critical patent/JP2019533642A5/ja
Application granted granted Critical
Publication of JP7065081B2 publication Critical patent/JP7065081B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019513944A 2016-09-12 2017-09-11 Gpr120モジュレーターとして有用な二環式化合物 Active JP7065081B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662393619P 2016-09-12 2016-09-12
US62/393,619 2016-09-12
PCT/US2017/050964 WO2018049328A1 (en) 2016-09-12 2017-09-11 Bicyclic compounds useful as gpr120 modulators

Publications (3)

Publication Number Publication Date
JP2019533642A JP2019533642A (ja) 2019-11-21
JP2019533642A5 true JP2019533642A5 (cg-RX-API-DMAC7.html) 2020-11-12
JP7065081B2 JP7065081B2 (ja) 2022-05-11

Family

ID=61562078

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019513944A Active JP7065081B2 (ja) 2016-09-12 2017-09-11 Gpr120モジュレーターとして有用な二環式化合物

Country Status (6)

Country Link
US (2) US10865201B2 (cg-RX-API-DMAC7.html)
EP (1) EP3509588B1 (cg-RX-API-DMAC7.html)
JP (1) JP7065081B2 (cg-RX-API-DMAC7.html)
KR (1) KR102539877B1 (cg-RX-API-DMAC7.html)
CN (1) CN110121343B (cg-RX-API-DMAC7.html)
WO (1) WO2018049328A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102537985B1 (ko) 2016-09-12 2023-05-30 인테그랄 헬스 인코퍼레이티드 Gpr120 조정제로서 유용한 단환형 화합물
CN110121343B (zh) * 2016-09-12 2023-11-03 整体健康 用作gpr120调节剂的双环化合物
WO2019202612A2 (en) * 2018-04-20 2019-10-24 Krish Biotech Research Private Limited Method of treatment of non-alcoholic steatohepatitis, nash
CN111499592B (zh) * 2020-03-14 2023-06-23 江苏省农用激素工程技术研究中心有限公司 5-氨甲基糖精的合成方法
CN111574414A (zh) * 2020-05-20 2020-08-25 上海毕得医药科技有限公司 一种4-溴-2-甲氧基苯磺酰氯的合成方法
CN114671827B (zh) * 2020-12-24 2024-09-20 杭州百新生物医药科技有限公司 邻苯甲酰磺酰亚胺类衍生物及其应用
CN114685395A (zh) * 2020-12-29 2022-07-01 浙江大学 一种2,3-二氢苯并[d]异噻唑类化合物及其应用
CN117143039A (zh) * 2022-08-29 2023-12-01 山东大学 一种苯并五元氮环类化合物、其制备方法及医药用途
CN116730945B (zh) * 2023-08-10 2023-11-17 北京惠宇乐邦环保科技有限公司 糖精的制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2735225A (en) 1956-02-21 Table ix p petri dish tests with x-phthalimido-
DE2253251A1 (de) * 1972-10-30 1974-05-09 Thomae Gmbh Dr K Neue phthalimido-sulfonylharnstoffe
DE3474547D1 (en) * 1983-12-02 1988-11-17 Shell Int Research Diphenyl ether herbicides
FR2659327A1 (fr) 1990-03-08 1991-09-13 Centre Nat Rech Scient Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
US5350761A (en) * 1991-07-30 1994-09-27 Ciba-Geigy Corporation Indolyl substituted hydroxylamine derivatives
US5334600A (en) * 1991-07-30 1994-08-02 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
ES2111059T3 (es) 1991-07-30 1998-03-01 Ciba Geigy Ag Derivados de hidroxilamina substituidos con heteroarilo como inhibidores de lipoxigenasa.
TW219935B (cg-RX-API-DMAC7.html) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
US5599811A (en) * 1995-02-21 1997-02-04 Warner-Lambert Company Benzothiazine dioxides as endothelin antagonists
JP3455229B2 (ja) 1996-03-29 2003-10-14 ファイザー インク. 6―フェニルピリジル―2―アミン誘導体
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
DE10348022A1 (de) * 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
TW200613272A (en) * 2004-08-13 2006-05-01 Astrazeneca Ab Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
WO2006038594A1 (ja) * 2004-10-04 2006-04-13 Ono Pharmaceutical Co., Ltd. N型カルシウムチャネル阻害薬
US8110681B2 (en) 2006-03-17 2012-02-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compounds for the treatment of spinal muscular atrophy and other uses
JP5421783B2 (ja) * 2006-12-27 2014-02-19 サノフイ Rhoキナーゼ阻害剤としての置換イソキノロン及びイソキノリノン誘導体
CN101646660A (zh) 2007-02-22 2010-02-10 Irm责任有限公司 调节g蛋白偶联受体的化合物和方法
WO2009014100A1 (ja) * 2007-07-20 2009-01-29 Chugai Seiyaku Kabushiki Kaisha p27蛋白質誘導剤
NZ592603A (en) * 2008-10-21 2013-02-22 Metabolex Inc Aryl gpr120 receptor agonists and uses thereof
AR074760A1 (es) 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
WO2010104195A1 (en) 2009-03-11 2010-09-16 Banyu Pharmaceutical Co.,Ltd. Novel isoindolin-1-one derivative
US8314120B2 (en) * 2010-03-30 2012-11-20 Abbott Gmbh & Co. Kg Small molecule potentiators of metabotropic glutamate receptors
US8299117B2 (en) 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
EP2582674B1 (en) 2010-06-16 2014-10-01 Cymabay Therapeutics, Inc. Gpr120 receptor agonists and uses thereof
TW201200505A (en) * 2010-06-17 2012-01-01 Metabolex Inc GPR120 receptor agonists and uses thereof
CA2841757A1 (en) 2011-07-15 2013-01-24 Etzer Darout Gpr 119 modulators
EP3587401A1 (en) 2011-11-30 2020-01-01 F. Hoffmann-La Roche AG New bicyclic dihydroisoquinoline-1-one derivatives
WO2014059232A2 (en) 2012-10-11 2014-04-17 Merck Sharp & Dohme Corp. Substituted spiropiperidinyl compounds useful as gpr120 agonists
KR101942752B1 (ko) 2012-11-05 2019-01-28 주식회사 엘지화학 Gpr120 효능제로서의 티오아릴 유도체
WO2014086663A1 (en) * 2012-12-03 2014-06-12 F. Hoffmann-La Roche Ag Substituted triazole and imidazole compounds
US9714252B2 (en) 2012-12-20 2017-07-25 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
AU2014241397B2 (en) 2013-03-14 2018-05-10 Janssen Pharmaceutica Nv Benzo-fused heterocyclic derivatives useful as agonists of GPR120
AU2014237600B2 (en) 2013-03-14 2018-03-22 Janssen Pharmaceutica Nv Bicyclic pyrrole derivatives useful as agonists of GPR120
DK3013796T3 (da) 2013-06-27 2020-03-16 Lg Chemical Ltd Biarylderivater som gpr120-agonister
TW201623286A (zh) * 2014-04-04 2016-07-01 賽諾菲公司 作為gpr119調控劑用於治療糖尿病、肥胖、血脂異常及相關病症之異吲哚啉酮化合物
AR100328A1 (es) 2014-05-07 2016-09-28 Bristol Myers Squibb Co Moduladores pirrolidina de gpr40
HRP20202032T1 (hr) 2014-08-29 2021-02-19 Chdi Foundation, Inc. Probe za snimanje huntingtonovog proteina
JP6486699B2 (ja) 2015-01-29 2019-03-20 国立大学法人金沢大学 脱水縮合剤
SG10201912959QA (en) * 2015-10-21 2020-02-27 Otsuka Pharma Co Ltd Benzolactam compounds as protein kinase inhibitors
KR102537985B1 (ko) * 2016-09-12 2023-05-30 인테그랄 헬스 인코퍼레이티드 Gpr120 조정제로서 유용한 단환형 화합물
CN110121343B (zh) * 2016-09-12 2023-11-03 整体健康 用作gpr120调节剂的双环化合物

Similar Documents

Publication Publication Date Title
JP2019533642A5 (cg-RX-API-DMAC7.html)
JP2019530674A5 (cg-RX-API-DMAC7.html)
JP2019519598A5 (cg-RX-API-DMAC7.html)
RU2470011C2 (ru) Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов
JP2018150302A5 (cg-RX-API-DMAC7.html)
JP2020519606A5 (cg-RX-API-DMAC7.html)
JP2013515074A5 (cg-RX-API-DMAC7.html)
JP2020528889A5 (cg-RX-API-DMAC7.html)
JP2019506430A5 (cg-RX-API-DMAC7.html)
JP2018518537A5 (cg-RX-API-DMAC7.html)
JP2019501133A5 (cg-RX-API-DMAC7.html)
JP2013010793A5 (cg-RX-API-DMAC7.html)
JP2019507781A5 (cg-RX-API-DMAC7.html)
JP2008520589A5 (cg-RX-API-DMAC7.html)
JP2013010792A5 (cg-RX-API-DMAC7.html)
JP2018534348A5 (cg-RX-API-DMAC7.html)
JP2018507886A5 (cg-RX-API-DMAC7.html)
JP2020502047A5 (cg-RX-API-DMAC7.html)
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2012517446A (ja) S1p5受容体の作動薬および拮抗薬ならびにそれらの使用方法
JP2017511339A5 (cg-RX-API-DMAC7.html)
JP2020519654A5 (cg-RX-API-DMAC7.html)
JP2012522759A5 (cg-RX-API-DMAC7.html)
JP2015510916A (ja) 慢性閉塞性肺疾患の急性増悪の治療におけるピラゾール誘導体の使用
JP2011500621A5 (cg-RX-API-DMAC7.html)